Video

The Need for Support


Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of thumbnail.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Image of Dr. Deville.
Image of Doctor.
Image of Dr. Tagawa.
Picture of Dr. Pouneh Razavi
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of a woman wearing a headband and glasses
Related Content